$402.84B
Revenue
$132.17B
Net Income
59.65%
Gross Margin
32.03%
Op. Margin
$116.47B
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $113.83B | $102.35B | $96.43B | $90.23B | $96.47B | $88.27B | $84.74B |
| Revenue Growth % (YoY) | 18.0% | 15.9% | 13.8% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $45.77B | $41.37B | $39.04B | $36.36B | $40.61B | $36.47B | $35.51B |
| Gross Profit | $68.06B | $60.98B | $57.39B | $53.87B | $55.86B | $51.79B | $49.23B |
| Gross Margin % | 59.8% | 59.6% | 59.5% | 59.7% | 57.9% | 58.7% | 58.1% |
| Operating Expenses | $77.89B | $71.12B | $65.16B | $59.63B | $65.50B | $59.75B | $57.32B |
| Research & Development | $18.57B | $15.15B | $13.81B | $13.56B | $13.12B | $12.45B | $11.86B |
| Operating Income | $35.93B | $31.23B | $31.27B | $30.61B | $30.97B | $28.52B | $27.43B |
| Operating Margin % | 31.6% | 30.5% | 32.4% | 33.9% | 32.1% | 32.3% | 32.4% |
| Other Income/Expense | $-24.94B | $12.76B | $2.66B | $11.18B | $-5.02B | $3.19B | $126.00M |
| Income Before Tax | $39.12B | $43.99B | $33.93B | $41.79B | $32.24B | $31.71B | $27.55B |
| Income Tax Expense | $4.66B | $9.01B | $5.74B | $7.25B | $5.71B | $5.41B | $3.93B |
| Net Income | $34.45B | $34.98B | $28.20B | $34.54B | $26.54B | $26.30B | $23.62B |
| Net Margin % | 30.3% | 34.2% | 29.2% | 38.3% | 27.5% | 29.8% | 27.9% |
| Basic EPS | 2.85 | 2.89 | 2.33 | 2.84 | 2.17 | 2.14 | 1.91 |
| Diluted EPS | 2.82 | 2.87 | 2.31 | 2.81 | 2.14 | 2.12 | 1.89 |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $30.71B | $23.09B | $21.04B | $23.26B | $23.47B | $19.96B | $27.23B |
| Short-term Investments | $96.14B | $75.41B | $74.11B | $72.06B | $72.19B | $73.27B | $73.50B |
| Accounts Receivable | $62.89B | $57.15B | $55.05B | $51.00B | $52.34B | $49.10B | $47.09B |
| Other Current Assets | $16.31B | $18.30B | $16.02B | $15.72B | $15.71B | $15.21B | $14.18B |
| Total Current Assets | $206.04B | $173.95B | $166.22B | $162.05B | $163.71B | $157.54B | $162.00B |
| Property Plant & Equipment | - | - | - | $185.06B | $171.04B | $161.27B | $151.16B |
| Goodwill | $33.38B | $33.27B | $32.34B | $32.17B | $31.89B | $31.93B | $29.18B |
| Long-term Investments | - | - | - | - | $266.00M | - | - |
| Other Non-current Assets | $16.25B | $16.81B | $14.15B | $12.95B | $14.87B | $13.87B | $9.70B |
| Total Assets | $595.28B | $536.47B | $502.05B | $475.37B | $450.26B | $430.27B | $414.77B |
| Accounts Payable | $12.20B | $10.55B | $8.35B | $8.50B | $7.99B | $7.05B | $6.09B |
| Accrued Liabilities | $55.56B | $59.44B | $52.04B | $58.30B | $51.23B | $46.59B | $47.30B |
| Deferred Revenue | $6.58B | $5.54B | $4.97B | $4.91B | $5.04B | $4.90B | $4.25B |
| Total Current Liabilities | $102.75B | $99.55B | $87.31B | $91.65B | $89.12B | $80.80B | $77.91B |
| Long-term Debt | $49.09B | $21.61B | $23.61B | $10.89B | $10.88B | $12.30B | $13.24B |
| Deferred Tax Liabilities | - | - | - | - | - | $706.00M | $717.00M |
| Other Non-current Liabilities | $8.45B | $6.27B | $6.24B | $6.12B | $4.69B | $1.45B | $1.75B |
| Total Liabilities | $180.02B | $149.60B | $139.14B | $130.11B | $125.17B | $116.15B | $114.02B |
| Common Stock | $93.13B | $91.69B | $89.28B | $86.72B | $84.80B | $82.03B | $79.73B |
| Retained Earnings | $324.06B | $297.23B | $275.76B | $262.63B | $245.08B | $235.32B | $226.03B |
| Total Stockholders Equity | $415.26B | $386.87B | $362.92B | $345.27B | $325.08B | $314.12B | $300.75B |
| Total Liabilities & Equity | $595.28B | $536.47B | $502.05B | $475.37B | $450.26B | $430.27B | $414.77B |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $34.45B | $34.98B | $62.74B | $34.54B | $26.54B | $26.30B | $23.62B |
| Stock-based Compensation | $7.07B | $17.88B | $11.51B | $5.52B | $5.81B | $16.98B | $11.13B |
| Change in Receivables | $5.20B | $3.58B | $1.20B | $-1.64B | $4.57B | $1.32B | $-110.00M |
| Change in Payables | $1.68B | $-771.00M | $-327.00M | $-880.00M | $401.00M | $-42.00M | $-563.00M |
| Operating Cash Flow | $52.40B | $112.31B | $63.90B | $36.15B | $39.11B | $86.19B | $55.49B |
| Capital Expenditure | $27.85B | $63.60B | $39.64B | $17.20B | $14.28B | $38.26B | $25.20B |
| Purchases of Investments | $42.94B | $60.83B | $39.87B | $18.45B | $21.64B | $65.03B | $43.01B |
| Investing Cash Flow | $-51.78B | $-68.52B | $-40.74B | $-16.19B | $-16.18B | $-29.36B | $-11.35B |
| Stock Repurchased | $5.50B | $40.21B | $28.71B | $15.07B | $15.55B | $46.67B | $31.38B |
| Dividends Paid | $2.54B | $7.51B | $4.98B | $2.43B | $2.44B | $4.92B | $2.47B |
| Financing Cash Flow | $7.03B | $-44.42B | $-26.03B | $-20.20B | $-19.04B | $-60.70B | $-40.60B |
| Net Change in Cash | $7.62B | $-376.00M | $-2.43B | $-202.00M | $3.51B | $-4.09B | $3.18B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $102.35B | $88.27B | $289.01B | $253.55B |
| Cost of Revenue | $41.37B | $36.47B | $116.77B | $105.69B |
| Operating Expenses | $71.12B | $59.75B | $195.90B | $172.13B |
| Research & Development | $15.15B | $12.45B | $42.52B | $36.21B |
| Operating Income | $31.23B | $28.52B | $93.11B | $81.42B |
| Other Income/Expense | $12.76B | $3.19B | $26.60B | $6.15B |
| Income Before Tax | $43.99B | $31.71B | $119.71B | $87.57B |
| Income Tax Expense | $9.01B | $5.41B | $21.99B | $13.99B |
| Net Income | $34.98B | $26.30B | $97.72B | $73.58B |
| Basic EPS | 2.89 | 2.14 | 8.06 | 5.96 |
| Diluted EPS | 2.87 | 2.12 | 7.99 | 5.90 |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $23.09B | $23.47B |
| Short-term Investments | $75.41B | $72.19B |
| Accounts Receivable | $57.15B | $52.34B |
| Other Current Assets | $18.30B | $15.71B |
| Total Current Assets | $173.95B | $163.71B |
| Goodwill | $33.27B | $31.89B |
| Other Non-current Assets | $16.81B | $14.87B |
| Total Assets | $536.47B | $450.26B |
| Accounts Payable | $10.55B | $7.99B |
| Accrued Liabilities | $59.44B | $51.23B |
| Deferred Revenue | $5.54B | $5.04B |
| Total Current Liabilities | $99.55B | $89.12B |
| Long-term Debt | $21.61B | $10.88B |
| Other Non-current Liabilities | $6.27B | $4.69B |
| Total Liabilities | $149.60B | $125.17B |
| Common Stock | $91.69B | $84.80B |
| Retained Earnings | $297.23B | $245.08B |
| Total Stockholders Equity | $386.87B | $325.08B |
| Total Liabilities & Equity | $536.47B | $450.26B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $34.98B | $26.30B | $97.72B | $73.58B |
| Stock-based Compensation | - | - | $17.88B | $16.98B |
| Change in Receivables | - | - | $3.58B | $1.32B |
| Change in Payables | - | - | $-771.00M | $-42.00M |
| Operating Cash Flow | - | - | $112.31B | $86.19B |
| Capital Expenditure | - | - | $63.60B | $38.26B |
| Purchases of Investments | - | - | $60.83B | $65.03B |
| Investing Cash Flow | - | - | $-68.52B | $-29.36B |
| Stock Repurchased | - | - | $40.21B | $46.67B |
| Dividends Paid | - | - | $7.51B | $4.92B |
| Financing Cash Flow | - | - | $-44.42B | $-60.70B |
| Net Change in Cash | - | - | $-376.00M | $-4.09B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.